Evidence map›Paper›PMID 19845794›Full record

ArticleImmunology2010

Clonal relationships between thyroid-stimulating hormone receptor-stimulating antibodies illustrate the effect of hypermutation on antibody function.

Carolyn J Padoa, Sanne L Larsen, Christiane S Hampe, Jacqueline A Gilbert, Elif Dagdan, Laszlo Hegedus, Deborah Dunn-Walters, J Paul Banga

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Carolyn J PadoaDivision of Gene and Cell Based Therapy, King's College London School of Medicine, London, UK.
Sanne L Larsen
Christiane S Hampe
Jacqueline A Gilbert
Elif Dagdan
Laszlo Hegedus
Deborah Dunn-Walters
J Paul Banga
King's College London · GBNational Health Laboratory Service · ZAOdense University Hospital · DKUniversity of Washington · US

Funding

Medical Research Council G0000160
6 · The paper itself

Abstract

Graves' disease is characterized by production of agonist antibodies to the thyroid-stimulating hormone receptor (TSHR), but knowledge of the genetic and somatic events leading to their aberrant production is limited. We describe the genetic analysis of two monoclonal antibodies (mAbs) with thyroid-stimulating activity (TSAb) obtained from a single mouse with experimental Graves' disease. The mAbs were class switched, but used the same rearrangement of immunoglobulin heavy chain, variable region (IGHV) and immunoglobulin light chain, variable region (IGLV) germline genes, implying a clonal relationship and derivation from a single precursor B-cell clone. The IGHV-region genes of the two mAbs underwent high degrees of somatic hypermutation by sharing numerous mutations before diverging, while the IGLV genes evolved separately. Interestingly, the mutations were present in both the complementarity-determining regions (CDRs) and the framework regions. The cloned IGHV and IGLV genes were confirmed to have TSAb properties in experiments in which they were expressed as recombinant Fabs (rFabs). In other experiments, we swapped the IGLV genes with IGHV genes by constructing chimeric rFabs and showed that the chimeras retained TSAb activities, confirming the close functional relatedness of the V-region genes. Importantly, the IGLV genes in chimeric rFabs had a dominant stimulatory effect at low concentrations, while the IGHV genes had a dominant effect at higher concentrations. Our findings demonstrate that, in experimentally immunized mice, multiple pathogenic antibodies to TSHR can arise from a single clone by a series of somatic mutations in the V-region genes and may give an insight into how such antibodies develop spontaneously in autoimmune Graves' disease.

Indexed as

Antibodies, MonoclonalAnimalsAntibody DiversityAutoimmunityComplementarity Determining RegionsDNA Mutational AnalysisDNA ShufflingGenetic EngineeringGraves DiseaseHybridomasImmunoglobulin Heavy ChainsImmunoglobulin lambda-ChainsImmunoglobulins, Thyroid-StimulatingMiceReceptors, ThyrotropinRecombinant Fusion ProteinsAntibodies, MonoclonalComplementarity Determining RegionsImmunoglobulin Heavy ChainsImmunoglobulin lambda-ChainsImmunoglobulins, Thyroid-StimulatingReceptors, ThyrotropinRecombinant Fusion Proteins

Identifiers

PMID19845794
PMCPMC2814471
OpenAlexW2031347521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.